Ali Aytuğ Kuştaş

ORCID: 0000-0003-0096-0311
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood groups and transfusion
  • Gastrointestinal Tumor Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Platelet Disorders and Treatments
  • Inflammatory Biomarkers in Disease Prognosis
  • Metastasis and carcinoma case studies

Ankara University
2020-2024

Immune thrombocytopenia (ITP) is treated by corticosteroids and/or intravenous immune globulin as the first line treatment when necessary. Mean platelet volume (MPV) a marker of production and function. In this study, we aimed to search relationship between MPV response in ITP patients it was hypothesized that can be used predictor response.The 70 newly diagnosed adult primary healthy people were included. population, diagnosis after responders nonresponders compared.The had significantly...

10.3906/sag-1912-242 article EN TURKISH JOURNAL OF MEDICAL SCIENCES 2020-03-17

Adjuvant chemoradiotherapy (CRT) is the optimal management strategy in resectable gastric cancer. There a debate about efficacy of more aggressive CRT plus chemotherapy regimens adjuvant setting. This study aimed to compare docetaxel-cisplatin-fluorouracil (DCF) versus fluorouracil-folinic acid (FUFA) stage III

10.4103/jcrt.jcrt_1009_20 article EN Journal of Cancer Research and Therapeutics 2024-04-01
Coming Soon ...